-

Blackstone Hires Michael Hovey, Former Co-Head of Insurance Investment Banking for North America at Morgan Stanley, to Lead Acquisitions for Blackstone Insurance Solutions

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE:BX) today announced that it has hired Michael Hovey as a Senior Managing Director to lead acquisitions and strategic partnerships for Blackstone Insurance Solutions (“BIS”). Mr. Hovey joins Blackstone from Morgan Stanley, where he was a Managing Director and most recently served as Co-Head of Insurance Investment Banking for North America. Inclusive of his nearly 17-year tenure with Morgan Stanley, Mr. Hovey brings over 23 years of insurance investment banking experience.

Mr. Hovey will be responsible for leading BIS’s investments, strategic partnerships and other transactions with insurance companies. He will report to Gilles Dellaert, Global Head of Blackstone Insurance Solutions. In total, Blackstone manages more than $60 billion in assets for insurance companies.

Gilles Dellaert, Global Head of Blackstone Insurance Solutions, said: “We’re thrilled to have Michael join Blackstone Insurance Solutions. As we continue to evaluate new investment opportunities in the insurance sector, having an individual with Michael’s deep experience, expertise and relationships will be a critical resource to our team.”

David Blitzer, Global Head of Blackstone Tactical Opportunities, said: “We’re excited to have a leader of Michael’s caliber on our insurance team. We see significant opportunities for continued growth ahead for our insurance business, and he will be a key part of that effort.”

Michael Hovey added: “Blackstone’s ability to deliver flexible capital solutions and its world-class investment management expertise makes it an ideal partner to insurance companies. I’m excited to work closely with Gilles and the entire Blackstone team as its insurance solutions business continues to execute on that mission.”

Prior to joining Morgan Stanley in 2004, Mr. Hovey was a Vice President in the Financial Institutions Group, Investment Banking at Lehman Brothers. Mr. Hovey received a BS from the University of Colorado Boulder, where he graduated summa cum laude.

About Blackstone

Blackstone is one of the world’s leading investment firms. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our asset management businesses, with $584 billion in assets under management, include investment vehicles focused on private equity, real estate, public debt and equity, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow Blackstone on Twitter @Blackstone.

Contacts

Matt Anderson
212-390-2472
matthew.anderson@blackstone.com

Blackstone

NYSE:BX

Release Versions

Contacts

Matt Anderson
212-390-2472
matthew.anderson@blackstone.com

More News From Blackstone

Blackstone Real Estate Debt Strategies Launches Homebuilder Lending Platform

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE: BX) today announced that Blackstone Real Estate Debt Strategies (“BREDS”) has launched a lending platform that will provide much needed capital and flexibility to homebuilders, and expects to enable the construction of over 50,000 for-sale homes across the United States annually. This lending platform is supported by BREDS portfolio company, Brio Homebuilder Solutions, as well as partnerships with third parties. This commitment comes at a time when t...

Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Advance Novel and Patient-Friendly Oral Enzyme Replacement Therapy for Pancreatic Insufficiency

NEW YORK & NATICK, Mass.--(BUSINESS WIRE)--Blackstone Life Sciences (“BXLS”) today announced a $250 million investment in Anagram Therapeutics (“Anagram”), a clinical-stage private biopharmaceutical company dedicated to improving the lives of people living with exocrine pancreatic insufficiency due to cystic fibrosis (“CF”), pancreatic cancer and related disorders. The investment will help fund the further development, approval and launch of Anagram’s ANG003, a novel orally delivered recombinan...

Anthropic Partners with Blackstone, Hellman & Friedman, and Goldman Sachs to Launch Enterprise AI Services Firm

SAN FRANCISCO--(BUSINESS WIRE)--Anthropic, Blackstone, Hellman & Friedman, and Goldman Sachs today announced the formation of a new AI-native enterprise services firm that will work with companies to rapidly bring Claude into their core business operations. The new firm is a standalone entity with Anthropic engineering and partnership resources embedded directly within its team. Alongside the founding partners, the new company is backed by a consortium of leading alternative asset managers...
Back to Newsroom